Search
for
Sort by
Research 391–420 of 1000+
- Cutaneous lupus erythematosus
- Adverse Cutaneous Reactions to Mood Stabilizers
- Adverse Cutaneous Reactions to Antidepressants
- Dermatolojik Problemler ve COVID-19
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- New onset of alopecia areata in a patient with SARS‐CoV‐2 infection: Possible pathogenetic correlations?
- Carbamazepine-Induced Hair Loss
- Heterogeneity of Polymorphous Light Eruption: A Study of 105 Patients
- Children with trichotillomania in COVID‐19 outbreak
- Manual of chemical peels: Superficial and medium depth
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Hypersensitivity Reactions to Anticoagulant Drugs
- Adverse Drug Reactions in HIV/AIDS Patients on Highly Active Antiretro Viral Therapy: A Review of Prevalence
- A study on dermatoses of pregnancy
- Psychoactive drugs and skin
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Dermal Mucinosis in the Eosinophilia-Myalgia Syndrome
- Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
- Adverse cutaneous effects of psychotropic medications
- Thermographic Follow-up of a Mild Case of Herpes Zoster
- Women's Dermatologic Diseases, Health Care Delivery, and Socioeconomic Barriers
- Skin
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Cutaneous drug reactions
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- Hair Product Allergy: A Review of Epidemiology and Management
- Hypersensitivity Reactions to Homemade Topical Preparations.
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study